Cerevel Therapeutics

Cerevel Therapeutics

  • Founded in 2018
  • 201-500 Employees

Careers at Cerevel Therapeutics


About Cerevel Therapeutics

Cerevel Therapeutics is a biopharmaceutical company dedicated to unraveling the mysteries of the brain to develop treatments for neuroscience diseases. The company focuses on addressing devastating neurological and psychiatric disorders, aiming to transform what is possible in neuroscience by making meticulously evaluated decisions to innovate and deliver new treatment options. Cerevel's research emphasizes understanding neurocircuitry deficits and translating this understanding into therapeutic advancements for those affected by some of the most challenging conditions. It operates with a mission to serve underserved areas and communities affected by these diseases, and has recently been acquired by AbbVie to further strengthen its neuroscience pipeline.